Low-Dose THC and Common Anti-Inflammatory Drug Hold Promise in Alzheimer’s Treatment
A new study suggests a combination approach may provide the benefits of THC treatment with fewer negative side effects.
24 results for “mma”
A new study suggests a combination approach may provide the benefits of THC treatment with fewer negative side effects.
Researchers say CBD in particular proved to be highly effective.
Selected cannabinoid and terpenes have the potential to reduce inflammation associated with a range of health conditions.
A newly discovered molecule has been shown to have potent anti-inflammatory properties.
Exercise is known to decrease chronic inflammation, but so far little is known as to how it does this.
Beyonce reveals she turned to CBD on her last tour to help with inflammation and soreness
The first results from a study into the impact of cannabinoids on respiratory diseases have been published
Curaleaf has acquired EMMAC Life Sciences in a landmark deal valued at $285 million. Cannabis Health speaks with EMMAC’s CEO to find out what the acquisition means for the sector […]
Recent studies suggest that medical cannabis can have a ‘significant’ impact on the symptoms of inflammatory bowel disease (IBD). Researchers exploring the effects of cannabis on those with IBD, including […]
An in-depth review has revealed the ‘promising potential’ of cannflavins for the treatment of inflammatory disorders, cancer, dementia and infectious disease. The review, carried out by researchers at Imperial College […]
Scientists in Israel believe medical cannabis could tackle one of the major causes of death in severely ill COVID-19 patients.
Cannabis may help some people with ADHD manage symptoms such as restlessness and impulsivity – but research suggests it could make other symptoms worse.
In this bi-weekly series, Dr Sue Clenton explores the growing interest and potential of cannabinoid-based therapies to address unmet needs in women’s health conditions.
Devon Partnership NHS Trust has approved procedures for patients to continue taking their prescribed cannabis-based medications while in hospital.
The study is evaluating MRX1, the company’s proprietary CBD-based oral solution, as a treatment for chemotherapy-induced peripheral neuropathy (CIPN).
Cannabis-derived molecules could help relieve chronic pain without the psychoactive effects associated with THC.
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
Two non-psychoactive cannabis compounds may help treat the most common form of chronic liver disorder.
In a fascinating deep dive into human physiology, Dr. Rowan Thompson, resident doctor and Vice Chair of the Medical Cannabis Clinicians Society (MCCS), explores the Endocannabinoid System (ECS)—a complex biological […]
The Hannah Deacon Campaign is calling on the government to support children unable to access medical cannabis on the NHS.
The company has cleared the final regulatory hurdle to begin its ENDOCAN Phase 2 trial in women with endometriosis-associated pain.
Early research suggests CBG-A could support cardiovascular health and reduce oxidative stress.